IL17A and acute respiratory distress syndrome: In addition, increased levels of IL-17A have been detected in SARS-CoV-, Middle East respiratory syndrome (MERS-CoV)-, and SARS-CoV-2-infected patients, especially in those with severe symptoms, suggesting a crucial role of IL-17 signaling in exacerbating severe ARDS (6, –, 8).